openPR Logo
Press release

COPD and Asthma Diagnostic and Monitoring Devices Market Size to Hit $8,202.62 Million by 2027

06-09-2021 05:40 PM CET | Health & Medicine

Press release from: Allied Market Research

COPD and Asthma Diagnostic and Monitoring Devices Market

COPD and Asthma Diagnostic and Monitoring Devices Market

COPD and asthma diagnostic and monitoring devices market accounted for $4,953.60 million in 2019, and is expected to reach $8,202.62 million by 2027, registering a CAGR of 6.3% from 2020 to 2027.

COPD and asthma diagnostic and monitoring devices are used to assist a patient who is having difficulty in breathing and cannot achieve adequate oxygen levels to maintain life. In addition, growth in geriatric population, tobacco consumption, allergens, and air pollutants increase the prevalence of respiratory diseases, which in turn drive the global COPD and asthma diagnostic and monitoring devices market.

Click Here To Access Sample Report @ https://www.alliedmarketresearch.com/request-sample/10932

The global COPD and asthma diagnostic and monitoring device market is estimated to grow during the forecast period, owing to factors such as increase in geriatric population, and advancements of COPD and asthma diagnostic and monitoring devices. Furthermore, technological innovation is one of the major factors propelling the market growth. The World Health Organization (WHO) had reported that asthma affects around 300 million people worldwide, and 250,000 have died due to Asthma globally. In 2019, approximately 65 million people had COPD across the globe; among that around 16 million Americans had COPD and is estimated to grow.

Moreover, air pollution, climate changes, and allergies propel the market growth. The development of technologically advanced devices, regulatory approvals, and product launches is driving the market growth. However, lack of awareness among individuals about COPD and asthma diagnostic and monitoring devices, especially in the underdeveloped countries and stringent regulatory procedures are hindering the growth of the market.

COPD and asthma diagnostic and monitoring device are being extensively used for diagnosis, monitoring, and controlling respiratory disorders. Rise in prevalence of respiratory diseases and increase in adoption of smoking & alcohol consumption are the primary factors fueling the market growth.

On the basis of product type, the diagnostic devices segment is most influencing segment in the COPD and asthma diagnostic and monitoring device market. This is attributed to increase in investment by the giant players and increase in research related funding made it convenient to use them, which further made them portable and automatic. All these factors are expected to propel growth of the market during the forecast period.

On the basis of indication, the asthma segment is estimated to garner largest share in 2019. It is expected to maintain its dominant position throughout the analysis period.

On the basis of end user, the hospital and clinics segment are estimated to gather the highest share in 2019. It is expected to maintain its dominant position throughout the analysis period. This is attributed to rise in number of patients diagnosed with respiratory diseases, increase in government initiatives, and technological upgradation in COPD & asthma devices. In addition, more than 5 million patients are admitted annually in the U.S., which will drive the market growth in the forecast period.

Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in 2019, and is expected to retain its dominance throughout the forecast period. This is attributed to the factors such as rise in prevalence of respiratory diseases as a consequence of unhealthy lifestyles and high stress levels.

Furthermore, incorporation of new reimbursement models for respiratory and monitoring solution procedures and stringent regulatory guidelines that are aimed toward medical efficacy, patient safety, and clinical efficiency are expected to drive the regional demand in the coming years. Furthermore, Asia-Pacific presents lucrative opportunities for key players operating in the COPD and asthma diagnostic and monitoring devices market, owing to increase in population coupled with high growing geriatric population. Furthermore, growth in awareness regarding COPD and asthma devices among healthcare entities drives the market growth.

For Purchase Enquiry: @ https://www.alliedmarketresearch.com/purchase-enquiry/10932

Key Findings Of The Study
• The study provides an in-depth analysis, current trends, and future estimations of the global COPD and asthma diagnostic and monitoring device market to elucidate the imminent investment pockets.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• By product type, the consumables and accessories segment are anticipated to grow at a CAGR of 7.4% from 2020 to 2027.
• By end user, hospitals and clinics dominated the COPD and asthma diagnostic and monitoring device market in 2019.
• Extensive analysis of key segments of the industry help understand the types of products and technologies used across various geographies.

Contact:
David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com
Follow Us on LinkedIn: https://www.linkedin.com/company/allied-market-research

About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release COPD and Asthma Diagnostic and Monitoring Devices Market Size to Hit $8,202.62 Million by 2027 here

News-ID: 2301822 • Views:

More Releases from Allied Market Research

Pet Treats Market Size Worth USD $29.7 Billion by 2031, Growth Rate (CAGR) of 4.2% From 2022-2031
Pet Treats Market Size Worth USD $29.7 Billion by 2031, Growth Rate (CAGR) of 4. …
𝐓𝐡𝐞 𝐏𝐞𝐭 𝐓𝐫𝐞𝐚𝐭𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 𝐒𝐢𝐳𝐞 𝐰𝐚𝐬 𝐯𝐚𝐥𝐮𝐞𝐝 𝐚𝐭 $𝟐𝟎.𝟏 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐢𝐧 𝟐𝟎𝟐𝟏, 𝐚𝐧𝐝 𝐢𝐬 𝐞𝐬𝐭𝐢𝐦𝐚𝐭𝐞𝐝 𝐭𝐨 𝐫𝐞𝐚𝐜𝐡 $𝟐𝟗.𝟕 𝐛𝐢𝐥𝐥𝐢𝐨𝐧 𝐛𝐲 𝟐𝟎𝟑𝟏, 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐚𝐭 𝐚 𝐂𝐀𝐆𝐑 𝐨𝐟 𝟒.𝟐% 𝐟𝐫𝐨𝐦 𝟐𝟎𝟐𝟐 𝐭𝐨 𝟐𝟎𝟑𝟏. According to a new report published by Allied Market Research, titled, "Pet Treats Market by Pet Type (Dog, Cat, Others), by Form (Organic, Conventional), by Sales Channel (Online, Offline): Global Opportunity Analysis and Industry Forecast, 2021-2031". The report provides a
Leisure Travel Market Surges: Going to Reach $1,737.3 Billion by 2027 with 22.6% CAGR Growth
Leisure Travel Market Surges: Going to Reach $1,737.3 Billion by 2027 with 22.6% …
According to a new report, titled, "Leisure Travel Market by Traveler Type, Sales Channel, By Age Group and By Expenditure Type: Opportunity Analysis and Industry Forecast, 2021-2027,". The report provides a detailed analysis of the top investment pockets, top winning strategies, drivers & opportunities, market size & estimations, competitive landscape, and changing market trends. The global leisure travel market size was valued at $1,006.5 billion in 2019, and is projected
Ecotourism Market is Rapidly Growing, Currently Valued At a $333.8 Billion with a CAGR of 14.3% From 2021-2027
Ecotourism Market is Rapidly Growing, Currently Valued At a $333.8 Billion with …
According to the report, The global "Ecotourism Market Size, Share, Competitive Landscape and Trend Analysis Report by Traveler Type, Age Group and Sales Channel : Global Opportunity Analysis and Industry Forecast, 2021-2027". The report offers an in-depth analysis of prime investment opportunities, effective winning strategies, key drivers and prospects, market size projections, competitive dynamics, and evolving market trends. The Ecotourism market size was valued at $181.1 billion in 2019, and
Cloud Storage Market Reach USD 222.25 Billion by 2027 at a CAGR of 21.9%, Top Factors Leading The Industry Worldwide
Cloud Storage Market Reach USD 222.25 Billion by 2027 at a CAGR of 21.9%, Top Fa …
Allied Market Research published a new report, titled, " The Cloud Storage Market Reach USD 222.25 Billion by 2027 at a CAGR of 21.9%, Top Factors Leading The Industry Worldwide." The report offers an extensive analysis of key growth strategies, drivers, opportunities, key segment, Porter's Five Forces analysis, and competitive landscape. This study is a helpful source of information for market players, investors, VPs, stakeholders, and new entrants to gain

All 5 Releases


More Releases for COPD

Copd CBD Gummies: Reviews (Shocking Facts) Copd CBD Oil "Ingredients" Pain Relie …
Copd CBD Gummies: With the increasing need for both individual and expert degrees, the stress and also stress are also enhancing. Individuals are using various methods to fight it. However, as a result of much less time for self, it is really hard. Here the natural herbs and supplements have actually discovered their way into our lives. The Copd CBD Oil are instances of super-effective natural supplements. The CBD existing
Power Harmonica to Cure Chronic Asthma & COPD
Power Harmonica is a free reed wind musical instrument. It is small rectangular shaped musical instrument. It has 48 number of holes which makes it special and different from other harmonica's. It's a pocket-friendly musical instrument. Power Harmonica is used as a natural treatment for many types of lung disorders and has no side effects. To play Power Harmonica there is no need of having a musical background it can be
COPD Therapeutics Global Market Research Report 2019
COPD Therapeutics Report by Material, Application, and Geography � Global Forecast to 2022 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germany, united Kingdom, Japan, South Korea and China). Access more details about this report at: https://www.research2reports.com/report-medical-devices/copd-therapeutics-market/80858 The report firstly introduced the COPD Therapeutics basics: definitions, classifications, applications and market
Global COPD and Asthma Devices Market Size
According to a new report, Global COPD and Asthma Devices Market, published by KBV Research, The Global COPD and Asthma Devices Market attained a market size of $ 27,465.1 Million in 2015 and is expected to reach $ 39,051.4 Million by 2022 growing at a CAGR of 5.2 % CAGR during 2016 – 2022. The Asia Pacific market dominated the Global COPD and Asthma Devices Market in 2015 and would
COPD Drug Market Opportunity & Clinical Pipeline Analysis
Close to 1 Billion people worldwide suffer from respiratory or pulmonary diseases. In the respiratory therapeutic domain, Asthma and COPD are the major categories, accounting for close to 75% of the total patient for respiratory or pulmonary diseases. Chronic obstructive pulmonary disease (COPD) is a disease which progresses in the lungs and requires treatment all through the life. It is an inflammatory disorder which is characterized by obstruction in the
04-10-2017 | Health & Medicine
TMR
Asthma and COPD Drugs Market: High Costs of Asthma and COPD Drugs and Consumer A …
Asthma is a disease characterized by recurrent attacks of coughing, chest-tightening, breathlessness, and wheezing as the airways narrow and swell that vary in severity and frequency. COPD is a disease of the lungs characterized by obstruction to airflow that interferes with normal breathing. According to the WHO, COPD accounted for over 3 million deaths in 2012, which is equal to 6% of all deaths globally in that year. Moreover, the